Top 50 Health Care VC Funds & Investors in Israel (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
OurCrowd
VC Fund
|
30 | Israel, United States, New Zealand | Series B, Series A, Seed | Software, Artificial Intelligence, Health Care | $604k–$62M |
|
Israel Innovation Authority
VC Fund
|
27 | Israel, United States, Mali | Grant, Seed, Pre-Seed | Health Care, Artificial Intelligence, Biotechnology | $100k–$6M |
|
Pontifax
VC Fund
|
21 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6.3M–$130M |
|
Trendlines Group
VC Fund
|
20 | Israel, Singapore, United Kingdom | Seed, Venture - Series Unknown | Health Care, Biotechnology, Medical Device | $650k–$62M |
|
OrbiMed
VC Fund
|
11 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $9.8M–$160M |
|
Accelmed
VC Fund
|
10 | United States, Israel | Series D, Series A | Health Care, Medical Device, Medical | $695k–$96M |
|
Triventures
VC Fund
|
10 | United States, Israel, Ireland | Series A, Series B, Seed | Health Care, Medical Device, Medical | $1M–$28M |
|
Agriline
VC Fund
|
9 | Israel | Seed, Series A, Venture - Series Unknown | Health Care, Medical, Biotechnology | $1.3M–$17M |
|
FutuRx
VC Fund
|
9 | Israel | Seed, Venture - Series Unknown | Biotechnology, Biopharma, Therapeutics | |
|
Firstime Venture Capital
VC Fund
|
9 | Israel, United States, United Kingdom | Seed, Series A, Series B | Software, Health Care, Artificial Intelligence | $600k–$42M |
|
aMoon Fund
VC Fund
|
9 | United States, Israel, France | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5.7M–$93M |
|
Pitango VC
VC Fund
|
9 | Israel, United States, United Kingdom | Series B, Series A, Series C | Software, Health Care, Information Technology | $4M–$100M |
|
Vertex Ventures Israel
VC Fund
|
8 | Israel, United States, Canada | Series A, Series B, Series C | Software, Information Technology, Artificial Intelligence | $3.5M–$100M |
|
Welltech Ventures
VC Fund
|
8 | Israel, United States, Poland | Seed, Series A, Venture - Series Unknown | Health Care, Artificial Intelligence, mHealth | $718k–$20M |
|
Kli Capital
VC Fund
|
8 | United States, Israel, Mexico | Seed, Series A | Health Care, Software, Wellness | $1.6M–$21M |
|
Terra Venture Partners
VC Fund
|
8 | Israel, United States | Seed, Series A, Series B | Software, Health Care, Machine Learning | $1M–$30M |
|
Maccabi Fund
VC Fund
|
7 | Israel, United States | Seed, Series A, Grant | Health Care, Artificial Intelligence, Medical Device | $1.5M–$15M |
|
RMGP Biopharma Investment Fund
VC Fund
|
7 | Israel | Seed, Series B, Venture - Series Unknown | Biotechnology, Biopharma, Therapeutics | |
|
Entrée Capital
VC Fund
|
7 | United States, Israel, United Kingdom | Seed, Series A, Series B | Software, FinTech, Financial Services | $1.5M–$54M |
|
GlenRock Israel
VC Fund
|
7 | Israel, United States | Seed, Series A, Series B | Software, Health Care, Cyber Security | $100k–$30M |
|
Docor International Management
VC Fund
|
7 | Israel, United States | Series C, Venture - Series Unknown | Health Care, Biotechnology, Medical Device | $8M–$22M |
|
Elron Ventures
VC Fund
|
7 | Israel, United States, China | Series A, Seed | Information Technology, Software, Cyber Security | $1M–$17M |
|
Sanara Ventures
VC Fund
|
7 | Israel | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Medical | $800k–$6M |
|
Longevity Venture Partners
VC Fund
|
7 | Israel, United States, United Kingdom | Seed, Pre-Seed, Series A | Health Care, Medical Device, Health Diagnostics | $1.2M–$11M |
|
Lightspeed Venture Partners
VC Fund
|
7 | United States, India, Israel | Series A, Series B, Seed | Software, Information Technology, Artificial Intelligence | $2M–$125M |
|
HBL Hadasit Bio Holdings
VC Fund
|
7 | Israel | Venture - Series Unknown, Seed, Series A | Biotechnology, Medical, Health Care | $10M–$47M |
|
SeedIL Ventures
VC Fund
|
6 | Israel, United States, United Kingdom | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, SaaS | $1.7M–$21M |
|
Joy Ventures
VC Fund
|
6 | Israel, United States | Series A, Seed, Grant | Health Care, Software, Wellness | $6M–$20M |
|
EISMEA
VC Fund
|
6 | Spain, Italy, United Kingdom | Grant, Venture - Series Unknown, Seed | Manufacturing, Biotechnology, Software | $53k–$2.6M |
|
Cybele Holdings
VC Fund
|
6 | Israel, United States, Cyprus | Post-IPO Equity, Venture - Series Unknown, Series D | Health Care, Biotechnology, Real Estate | $519k–$98M |
|
Sarona Ventures
VC Fund
|
6 | Israel, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Information Technology, Artificial Intelligence | $100k–$25M |
|
fresh.fund
VC Fund
|
6 | Israel, United States, Norway | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $300k–$21M |
|
ALIVE Israel HealthTech Fund
VC Fund
|
6 | Israel, United States | Series A, Series C, Venture - Series Unknown | Health Care, Medical, Biotechnology | $4.4M–$105M |
|
J-Ventures
VC Fund
|
6 | United States, Israel | Series A, Seed, Pre-Seed | Software, Health Care, Machine Learning | $200k–$27M |
|
Grove Ventures
VC Fund
|
6 | Israel, United States | Seed, Series A, Series B | Artificial Intelligence, Software, Machine Learning | $3.3M–$74M |
|
PipelBiz.com
VC Fund
|
6 | Israel, United States, United Kingdom | Equity Crowdfunding, Seed | Software, Health Care, Medical | $150k–$2.8M |
|
Integra Holdings
VC Fund
|
5 | Israel | Seed, Series B, Series F | Biotechnology, Pharmaceutical, Life Science | |
|
Johnson & Johnson Robotics and Digital Solutions
VC Fund
|
5 | United States, Israel, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $300k–$100M |
|
Arkin Holdings
VC Fund
|
5 | Israel, United States, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2M–$95M |
|
TAU Ventures
VC Fund
|
5 | Israel, United States | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Enterprise Software | $370k–$28M |
|
Connecticut Innovations
VC Fund
|
5 | United States, Israel, Canada | Seed, Series A | Health Care, Biotechnology, Software | $150k–$25M |
|
XTX Ventures
VC Fund
|
5 | United Kingdom, United States, Israel | Series A, Seed | Artificial Intelligence, Software, Machine Learning | $2M–$60M |
|
Pfizer
VC Fund
|
5 | United States, Israel, France | Series A, Post-IPO Equity, Seed | Biotechnology, Health Care, Pharmaceutical | $800k–$320M |
|
Rimonci Capital
VC Fund
|
5 | Israel, France, United States | Series A, Seed, Series B | Health Care, Medical Device, Eyewear | $3.6M–$11M |
|
Good Seed Ventures
VC Fund
|
5 | Germany, Israel, United States | Seed, Series A, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | $55k–$50M |
|
iAngels
VC Fund
|
5 | United States, Israel, United Kingdom | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Financial Services | $120k–$22M |
|
New York Angels
VC Fund
|
5 | United States, Israel, United Kingdom | Seed, Series A, Series B | Software, Health Care, Mobile | $325k–$15M |
|
Clal Biotechnology Industries
VC Fund
|
5 | Israel, United States | Series A, Series B | Health Care, Biotechnology, Medical Device | $4M–$55M |
|
Tal Ventures
VC Fund
|
5 | Israel, United States, Cyprus | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, SaaS | $2.1M–$25M |
|
XT Venture Capital
VC Fund
|
5 | Israel, Singapore, United States | Series A, Seed, Series B | Software, Health Care, Travel | $3.2M–$100M |
| Access all 1323 VC funds in Israel Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series B, Series A, Seed
- Geography: Israel, United States, New Zealand
Investor stats
- Total investments: 372
- Round size: Seed $604k–$9.5M; Series A $4.5M–$22M; Series B $7M–$62M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely actively investing — fresh fund, raised $230k in 2026
Portfolio highlights
- N.Light — N.Light is a Metaverse 3D design software that allows individuals to effortlessly turn their ideas into reality.
- Hemispheric — Hemispheric develops fundamental AI technologies aimed at deciphering brain activity for innovative applications.
- MUV Interactive — MUV Interactive designs and develops innovative technology for active human sensing, providing a natural and fluent interactive experience with any type of digital application, from displayed content, and smart home appliances to IOT (Internet of Things) devices, drones and AR/VR applications. The company’s flagship product, Bird, is anintuitive device that is worn on the index finger, which transforms any space into a 3D Interactive Environment. Bird is the first device to integrate the entire spectrum of input and control methods – including touch, remote touch, gesture control and mouse functionality. This gives users the flexibility to interact with each type of digital content in the most intuitive way, whether up close or from a distance of up to 100 feet away.
The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Biotechnology
- Stage:Grant, Seed, Pre-Seed
- Geography: Israel, United States, Mali
Investor stats
- Total investments: 217
- Round size: Seed $400k–$6M; Grant $130k–$3.5M; Pre-Seed $100k–$2.1M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $10M in 2023
Portfolio highlights
- Brevel — Brevel developed a disruptive cultivation technology for sustainable, low cost and high quality production of microalgae for various yet untapped markets. The technology is based on high-tech indoor, sterile and fully automated systems which are illuminated from within at high intensity. The technology enables the surprising results of more than90% cost reduction and up to 200 higher yields compared to current alternatives. Brevel is using the advantageous production capabilities to enter multiple markets where microalgae derived products are needed.
- PulseNmore — Pulsenmore (TASE:PULS) is a world leader in self-scan ultrasound devices for remote clinical diagnosis and screening.
- GeoRank Studio — Get your business ranked on Google, cited by ChatGPT & Perplexity, and protected from reputation damage. Specialist SEO and GEO agency. Free consultation.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 122
- Round size: Series A $6.3M–$110M; Series B $20M–$130M; Series C $22M–$101M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $14M in 2020
Portfolio highlights
- Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
- Crystalys Therapeutics — Transforming care for people living with gout.
- Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Venture - Series Unknown
- Geography: Israel, Singapore, United Kingdom
Investor stats
- Total investments: 70
- Round size: Seed $650k–$4.1M; Venture - Series Unknown $1M–$62M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $40M in 2019
Portfolio highlights
- IBI-Ag — We develop a wide array of selective bio-insecticides to help farmers grow more at lower cost with no harm to farm workers, consumers and the environment.
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 740
- Round size: Series A $9.8M–$140M; Series B $24M–$148M; Series C $19M–$160M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fresh fund, raised $192M in 2026
Portfolio highlights
- Insilico Medicine — Artificial Intelligence for Drug Discovery and Aging Research
- Star Therapeutics — Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
- Affimed — At Affimed, they are committed to improving outcomes for patients with cancer. Their scientific team has been devoted to unlocking the power of the innate immune system for nearly two decades to provide a unqiue approach to fighting cancer. With their unparalleled expertise in innate immunity and innate cell engager-based medicines, they aim toovercome the limitations and challenges faced by current immuno-oncology (I-O) therapies.
Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series D, Series A
- Geography: United States, Israel
Investor stats
- Total investments: 41
- Round size: Series A $695k–$24M; Series D $13M–$96M
- Lead/follow: 46% lead, 54% follow
- Last fund: May invest from a new fund soon — raised $401M in 2020
Portfolio highlights
- Corvia Medical — Corvia Medical is a medical device company, focuses on developing structural heart devices for the treatment of heart failure. The company develops InterAtrial Shunt Device (IASD), a transcatheter device designed to treat diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). It was founded in 2009and headquartered in Andover, Massachusetts.
- UltraClear — UltraClear is a skincare clinic that provides facial rejuvenation solutions for the treatment of all skin types.
- GT Medical Technologies — GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2Canadian issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.
Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Series B, Seed
- Geography: United States, Israel, Ireland
Investor stats
- Total investments: 60
- Round size: Seed $1M–$16M; Series A $6M–$24M; Series B $6M–$28M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $100M in 2015
Portfolio highlights
- Grin — Grin is a comprehensive digital orthodontic platform providing teeth straightening for all types of patients with a real local orthodontist. The platform also connects patients with a real orthodontist from the convenience of their smart device. They deliver responsible care from orthodontic specialists in an easily accessible and cost-effectiveway, Grin provides patients quality care that results in an exceptional smile together with all of the modernized convenience that they expect.Grin technology, aligned with a network of local trusted orthodontists, ensures that every patient gets the right care. The platform Grin App and Grin Scope is a patent-pending technology that offers remote monitoring for a variety of orthodontic needs. The Grin experience includes high-quality self-scans with the latest teeth straightening solutions. Practitioners and patients can now use these telemedicine tools to achieve a new, more convenient treatment journey.It was founded by Dr. Adam Schulhof, Pamela Oren-Artzi, and Alon Lipnik in 2019 and is based in New York and Austin.
- Cala Health — Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
- TailorMed — Moving Mountains for Patients
Agriline is the investment vehicle owned by a trust of which Trendlines' controlling shareholder Vincent Tchenguiz.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Israel
Investor stats
- Total investments: 15
- Round size: Seed $1.3M–$7.5M; Series A $5M–$17M; Venture - Series Unknown $2.2M–$16M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
- SetBone Medical — SetBone Medical develops a new bone cement for the treatment of VCF and primarily caused by osteoporosis.
FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.
Show more...Investment focus
- Industry: Biotechnology, Biopharma, Therapeutics
- Stage:Seed, Venture - Series Unknown
- Geography: Israel
Investor stats
- Total investments: 10
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- A2i Therapeutics — A2i Therapeutics develops novel therapeutic modulators of the protein that helps to control the immune response and neurological disorders.
- Skip Therapeutics — Skip Therapeutics develops precision, RNA-based, treatments for rare genetic diseases. Millions of people worldwide are affected by thousands of rare genetic disorders, yet the limited patient populations, further divided by patient-specific mutations, have hampered the discovery of effective treatments. Recent developments in RNA-therapeuticsprovide an enlarged molecular toolkit that can be used quickly and affordably to repair damaged genes' ability to make proteins. Computational techniques could be used to help identify sub-patient populations that would be eligible for treatment with RNA-based therapeutics and match molecular therapy options across the large landscape of known disease-causing mutations.
- Selene Therapeutics — Selene Therapeutics is developing a new therapeutic strategy for treating refractory epilepsy by the regulation of the neuronal activity set point by a reduction of the neuronal mean firing rate (MFR).Selene aims to develop small molecule inhibitors of Dihydroorotate dehydrogenase (DHODH), a mitochondrial enzyme located on the inner mitochondrialmembrane and participating in several key cellular homeostatic processes.
Endurance is a direct lending firm providing tailored senior secured credit facilities to companies and projects with proven technologies, visible commercial demand and capital requirements that are often underserved by conventional financing providers.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 98
- Round size: Seed $600k–$6M; Series A $1M–$10M; Series B $5M–$42M
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — raised $50M in 2017
Portfolio highlights
- Baibys — Baibys is a medical automated platform that provides AI and robotics-based autonomous sperm selection solutions for IVF.
- Remepy — Redefining combination therapy by fusing traditional pharmaceuticals with clinically validated app-delivered protocols in a single, regulated prescription.
- STAX Engineering, Inc. — The STAX mission is to help 1 billion people significantly through new technologies that promote health, sustainability, reduced environmental toxins, and reduced global warming.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 80
- Round size: Series A $5.7M–$82M; Series B $22M–$93M; Series C $30M–$82M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — raised $340M in 2022
Portfolio highlights
- Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
- Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
- Hopscotch Primary Care — We provide primary care services to seniors on Medicare, offering more time with your doctor, and a full care team to support all of your healthcare needs.
Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series B, Series A, Series C
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 327
- Round size: Series A $4M–$47M; Series B $8.1M–$55M; Series C $7.8M–$100M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Convizit — Convizit's AI automatically captures user actions, adds properties, and delivers this behavioral data directly into your analytics and marketing platforms.
- Catch — Catch is the trusted AI Executive Assistant that actually gets work done.
- QuantHealth — Quant Health offers drug simulation, computational biology, clinical data science, respiratory, trial simulation, and oncology services.
We partner early with global-minded entrepreneurs seeking to disrupt large markets
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B, Series C
- Geography: Israel, United States, Canada
Investor stats
- Total investments: 189
- Round size: Series A $3.5M–$28M; Series B $5M–$35M; Series C $5.6M–$100M
- Lead/follow: 17% lead, 83% follow
- Last fund: Likely still investing — raised $170M in 2022
Portfolio highlights
- Rylo — Nagish captions your phone calls and empowers you to talk using text or voice. It's fast, private, and free.
- Aternity — Unlocking the full potential of your digital experiences has never been more accessible. Illuminate, accelerate and fully leverage the full breadth of possibilities with Riverbed.
- Quantum Art — Quantum Art develops scalable, multi-core quantum computers with advanced trapped ion qubits and multi-qubit gates, accelerating breakthroughs in AI, finance, and materials science.
Welltech Ventures is Israel’s leading fund focused exclusively on investing in the health and wellness space. We seek to partner with entrepreneurs who epitomize the Startup Nation’s ethos and are building paradigm-shattering companies that are making an impact in the wellness space. As thought leaders we work with global investors focused onaccessing and investing in the Israeli tech ecosystem’s most promising entrepreneurs.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, mHealth
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Israel, United States, Poland
Investor stats
- Total investments: 23
- Round size: Seed $718k–$19M; Series A $6M–$20M; Venture - Series Unknown $3M–$5.3M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- MDI Health — Transform Quality Metrics Clinical Outcomes & Costs all inOne Platform. Your AI Co-Pilot for Medication Management
- Antidote Health — AntidoteHealth.ai offers primary care on its telehealth app on a 24/7 basis, including prescriptions & more. Book your appointment today!
- Marquee — Marquee turns football data into decision-ready insights in seconds, unifying external and internal data and filtering it through your club's sporting DNA.
Kli Capital is a firm focused on investing in fearless entrepreneurs who are building foundational enterprise technologies and ubiquitous consumer brands. We partner with exceptional founders with unique insights, from inception through all phases of growth.
Show more...Investment focus
- Industry: Health Care, Software, Wellness
- Stage:Seed, Series A
- Geography: United States, Israel, Mexico
Investor stats
- Total investments: 107
- Round size: Seed $1.6M–$8M; Series A $2.2M–$21M
- Lead/follow: 2% lead, 98% follow
- Last fund: Likely still investing — raised $50M in 2022
Portfolio highlights
- Prograd — ProGrad develops a credit risk assessment platform to connect financial institutions with third-level students looking for funding. Its platform includes Artificial Intelligence in credit scoring to lend responsibly to young customers with thin credit files based on future earning potential.The company was founded in 2020 and is headquartered inLondon, England.
- Longevity AI — Defy aging with personalized AI
- Sequent — Sequent is a pioneering online voting platform that utilizes advanced cryptographic technology and an open-source development approach to ensure online elections are secure, transparent and 100% verifiable.
We are an early stage venture capital firm dedicated to partnering with inspiring entrepreneurs to build breakthrough companies
Show more...Investment focus
- Industry: Software, Health Care, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 41
- Round size: Seed $1M–$2.5M; Series A $2.1M–$14M; Series B $15M–$30M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $9.6M in 2021
Portfolio highlights
- ViewNetic — ViewNetic is an AgTech startup developing unique imaging and machine learning technologies for early, pre-propagation detection of pests and diseases in high-value crops.
- Infiniplex — Infiniplex is an Israel-based startup whose mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at a more accessible and affordable cost. Our goal is to identify common and rare cancer types through a standard, inexpensive blood test that could becarried out as part of routine checkups, leveraging existing laboratory equipment and know-how. We aim to include tumor genomic testing as part of people's standard blood test checkups. The company was founded in 2021 and is based in Yokne'am Illit, Israel.
- Intuition Robotics — The AI care companion robot for older adults
Maccabi Fund is an investment fund.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Medical Device
- Stage:Seed, Series A, Grant
- Geography: Israel, United States
Investor stats
- Total investments: 11
- Round size: Seed $1.5M–$6.7M; Series A $1.5M–$15M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- AccuLine — AccuLine is a digital healthcare company, which was founded with the vision to saves the lives of millions of people worldwide. AccuLine is developing CORA—a smart, accurate, and easy to use exam for the early detection of coronary artery disease. The clinically validated CORA evaluates a patient's risk of having coronary artery diseasethrough advanced analysis and detection of two newly discovered biomarkers in the heart’s electrical activity. CORA’s early detection will assist in the prevention of sudden cardiac deaths, while lowering costs of cardiovascular related illness.
- Olive Diagnostics — It's About me (IAM) has developed a passive sensor mounted to the rim of the toilet that performs urinalysis every time the end-user urinates. The information is uploaded to a robust data science platform to track existing and progressing conditions. Real-time, actionable notifications will be sent to the end user for proactive medical ornutritional care. Ongoing biomarker tracking for hydration, Alcohol, Pregnancy, Ovulation, Keytones, etc. is used to develop a comprehensive personal user profile.The technology will also be used for pharma and CRO companies to track the usage of drugs. While drug compliance issues plague health care systems around the world, I AM's technology will provide a reliable and continuous solution for tracking when and how people take their medicine or clinical trial drug.Nonindustrial nations will now have home access to urine lab services.
- Rhino Federated Computing — Rhino Federated Computing solves one of the biggest challenges in AI: seamlessly connecting siloed data through federated computing.
RMGP Biopharma Investment Fund is an investment Fund
Show more...Investment focus
- Industry: Biotechnology, Biopharma, Therapeutics
- Stage:Seed, Series B, Venture - Series Unknown
- Geography: Israel
Investor stats
- Total investments: 8
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Circuit-Bio — Circuit-Bio is a synthetic biology company developing a unique platform of logical gene circuits for cancer immunotherapy. The platform used by the company focuses on creating gene circuits that can precisely and locally manufacture a combination of several immune-stimulating proteins (immunomodulators) that are only expressed in specific tumorcells. The circuit turns cancer cells into "Trojan horses" that are used as anti-tumor resources and incite a potent, long-lasting immune response.
- Skip Therapeutics — Skip Therapeutics develops precision, RNA-based, treatments for rare genetic diseases. Millions of people worldwide are affected by thousands of rare genetic disorders, yet the limited patient populations, further divided by patient-specific mutations, have hampered the discovery of effective treatments. Recent developments in RNA-therapeuticsprovide an enlarged molecular toolkit that can be used quickly and affordably to repair damaged genes' ability to make proteins. Computational techniques could be used to help identify sub-patient populations that would be eligible for treatment with RNA-based therapeutics and match molecular therapy options across the large landscape of known disease-causing mutations.
- Selene Therapeutics — Selene Therapeutics is developing a new therapeutic strategy for treating refractory epilepsy by the regulation of the neuronal activity set point by a reduction of the neuronal mean firing rate (MFR).Selene aims to develop small molecule inhibitors of Dihydroorotate dehydrogenase (DHODH), a mitochondrial enzyme located on the inner mitochondrialmembrane and participating in several key cellular homeostatic processes.
We are a team of former serial founders managing $1.5Bn across a number of funds, with offices in Tel Aviv, London, and New York. We back the next generation of category-defining companies with conviction of founders who have built companies themselves.We back founders with a partnership built on trust, fairness and real operating experience. Westand with founders through every challenge, and help them grow with clarity, resilience and purpose.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 306
- Round size: Seed $1.5M–$15M; Series A $5M–$30M; Series B $17M–$54M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely actively investing — fresh fund, raised $175M in 2025
Portfolio highlights
- Classiq Technologies — A software platform that helps users create scalable complex quantum computer algorithms, software, and circuits for any gate-based quantum computer
- Identiq — Identiq's network members fight fraud and improve user experience by validating new users and vouching for ones they already know without sharing any personal user data at all.
- Archy — SaaS Practice Management Software for Dental Practices
A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.
Show more...Investment focus
- Industry: Software, Health Care, Cyber Security
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 37
- Round size: Seed $1M–$9M; Series A $1.5M–$12M; Series B $100k–$30M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
- MSICS Pharma — MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for medical purpose.
- Quris — Quris Technologies is a bio-AI clinical-prediction platform is being developed to assure the safety and efficacy of medications.The company provides a fully automated, self-training AI platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively while minimizing animal testing, allowing pharmacompanies to avoid the enormous risks and costs of failed clinical trials and end the reliance on ineffective animal testing.Quris Technologies was established in 2019 by Isaac Bentwich in Tel Aviv, Israel.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series C, Venture - Series Unknown
- Geography: Israel, United States
Investor stats
- Total investments: 18
- Round size: Series C $13M–$22M; Venture - Series Unknown $8M–$15M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
- SP Nano — SP Nano is a nanotechnology company commercializing the use of nano-particles in the rapidly growing $106 billion composites market. The most widely-used type of composite consists of layers of fabric (carbon-fiber, glass-fiber, aramid) held together by a resin matrix. The matrix is the materials' weakest link - much weaker than the layersof fibers it binds. When composite structures and components commonly used in the aerospace, defense, automotive, marine and sporting goods industries fail, it's often because of this large discrepancy in strength between the fibers and the resin.
- Raziel Therapeutics — Raziel's drug aims for fat melting by harnessing the body’s own natural healing power and delivering proven biological activity.
Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.
Show more...Investment focus
- Industry: Information Technology, Software, Cyber Security
- Stage:Series A, Seed
- Geography: Israel, United States, China
Investor stats
- Total investments: 66
- Round size: Seed $1.5M–$15M; Series A $1M–$17M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Brainsgate — BrainsGate's platform technology involves electrical stimulation of the Spheno-Palatine Ganglion (SPG), a nervous center known to increase cerebral blood flow. BrainsGate is exploring several applications for its technology, and is currently focusing on treatment of acute ischemic stroke. Building on its technology, the Company has developedthe ISS, based on a miniature electrode implanted at the roof of the mouth in a bed side, minimally invasive, local anesthesia procedure comparable to dental treatment. In 2008, the company completed ImPACT-1, a pilot clinical trial for acute ischemic stroke with promising results. In 2011 the Company completed a 300 patients RCT pivotal trial that further substantiated the safety and efficacy of its treatment for acute ischemic stroke patients. BrainsGate is currently running the ImpACT-24b, a multi-national, randomized, double-blind, sham-controlled pivotal study to assess the safety and efficacy of its treatment for stroke patients in a 24-hour window.
- Raven.io — Secure apps with our Runtime Protection Platform. De-prioritize 99% of vulnerabilities with runtime reachability and prevent exploits, zero-days and supply chain attacks with intelligent, library-level policies.
- CyberRidge — CyberRidge is a deep-tech cybersecurity firm that develops photonic encryption to protect data privacy.
Sanara Ventures is an innovation-investment platform, elevating outstanding healthcare-technology companies, from early-stage to global market maturity. At Sanara, They share a vision of an integrated continuum of care supported by accessible advanced healthcare solutions for people around the world.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 9
- Round size: Seed $800k–$2.7M; Pre-Seed $800k–$1M; Series A $4M–$6M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Panacea-ml — Panacea-ml revolutionizes clinical trial design with its data-driven, explainable-AI SaaS platform. Our cutting-edge technology addresses the primary causes of clinical development failure by identifying patient profiles that maximize therapeutic efficacy, minimize safety risks, and improve participant retention. Leveraging historical clinicaltrials and millions real-world patient health records, Panacea-ml's AI model enhances patient selection criteria, reduces cohort sizes, and uncovers novel marker-endpoint interrelations, surrogate markers, and causal relationships beyond simple statistical correlations.Our platform is a game-changer for the pharmaceutical industry, facilitating seamless collaboration across drug development, data science, and clinical teams. It accelerates drug development by generating precise sub-population profiles, refining patient selection criteria, and providing informed go/no-go decisions for each phase of development. Panacea-ml is versatile, supporting small sample sizes and various therapeutic domains, including rare diseases and early development stages.At Panacea-ml, we believe in empowering innovation and fostering collaboration to drive impactful outcomes. Our mission is to shorten time to market and enable early access to innovative treatments for patients worldwide.
- CVAid Medical — CVAid Medical develops an innovative AI based stroke detection technological platform.
- TailorMed — Moving Mountains for Patients
Longevity Venture Partners is an early-stage venture capital firm committed to assisting entrepreneurs in the Silvertech, Healthcare, and Wellness sectors.
Show more...Investment focus
- Industry: Health Care, Medical Device, Health Diagnostics
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 13
- Round size: Seed $4M–$11M; Pre-Seed $1.2M–$3.6M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- CustoMED — End-to-end platform turning medical scans into patient-specific surgical plans, tools & implants instantly. AI-powered surgical planning in minutes.
- Sensifai Health — Powered by insights from wearables, Sensifai alerts inflammatory flares before symptoms enabling true early intervention.
- Urologic Health — Urologic Health developing innovative solutions to improve bladder function diagnosis, monitoring, and treatment of urinary disorders.
Lightspeed Venture Partners is a multi-stage venture capital firm focused on accelerating disruptive innovations and trends.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, India, Israel
Investor stats
- Total investments: 2378
- Round size: Seed $2M–$26M; Series A $7M–$85M; Series B $15M–$125M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fresh fund, raised $600M in 2025
Portfolio highlights
- Brale — One regulated system for stablecoin issuance, custody, payments, and compliance. 75+ programs in production across 45 US jurisdictions. SOC 2 Type II. Book a demo.
- Tennr — Tennr is a custom AI assistant that accelerates research, answers complex questions, and generates custom reports.
- Ricursive Intelligence — We develop frontier AI methods to reinvent chip development, collapsing traditional design timelines, closing the loop between AI and the hardware that fuels it, and enabling a Cambrian explosion of custom silicon.
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 11
- Round size: Venture - Series Unknown $10M–$47M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
We invest in the best Israeli founders. Boutique seed-stage VC with personalized support and international connections.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 32
- Round size: Seed $1.7M–$8M; Series A $2.2M–$21M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- BlinqIO — Autonomously develop and maintain flawless automation code, combining Generative AI's power with human oversight for scalable testing solutions
- Quack — Get your team the power to resolve user issues right away.
- Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
We support cutting-edge neuroscience research and build and fund ambitious companies on their journey to bring life-changing solutions to market.
Show more...Investment focus
- Industry: Health Care, Software, Wellness
- Stage:Series A, Seed, Grant
- Geography: Israel, United States
Investor stats
- Total investments: 12
- Round size: Series A $6M–$20M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $50M in 2017
Portfolio highlights
- NextSense — Introducing NextSense Smartbuds: EEG-powered earbuds that go beyond sleep tracking. Backed by science, Smartbuds provide real-time insights to help you achieve deeper, more restorative sleep. Comfortable, intuitive, and easy to use, Smartbuds empower you to wake up your best self.
- GrayMatters Health — GrayMatters Health- Re-imagine mental health care. Transforming neuroscience-based innovation into accessible mental health therapy to help change lives.
- Reflect Innovation — Reflect's Orb helps you find calm in just a few minutes based on your physiological signals with home biofeedback. Eliminate anxiety and return to well-being.
Investment focus
- Industry: Manufacturing, Biotechnology, Software
- Stage:Grant, Venture - Series Unknown, Seed
- Geography: Spain, Italy, United Kingdom
Investor stats
- Total investments: 3116
- Round size: Seed $53k–$914k; Grant $54k–$2M; Venture - Series Unknown $60k–$2.6M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- AGADE — Esoscheletri Agade | Il primo esoscheletro intelligente per lavoratori progettato per ridurre il rischio di disturbi muscolari delle spalle nella movimentazione manuale dei carichi.
- BroadBit Batteries — BroadBit is a technology company developing revolutionary new batteries using novel sodium-based chemistries to power the future green economy.
- Aenitis Technologies — We develop innovative devices for cells therapy processing using Acoustic Radiation Forces.
Cybele Group is a full service consulting and financial services firm, which provides investment banking, brokerage and asset management services to both corporations and a wide array of clients, ranging from individuals and small businesses to the world's largest corporations and governments.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Real Estate
- Stage:Post-IPO Equity, Venture - Series Unknown, Series D
- Geography: Israel, United States, Cyprus
Investor stats
- Total investments: 66
- Round size: Post-IPO Equity $787k–$77M; Venture - Series Unknown $519k–$98M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Silverbyte — Optima is an international, top notch Hotel Management Software solution for medium to high end hotels and groups with over 1000 installations in 34 countries.
- Cannabotech — Cannabotech develop, and assimilate the medicinal properties of Cannabinoids & Mushrooms, integrated with cutting-edge technologies at world-class standards.
- Smart Agro — Smart Agro specializes in investing and improving companies in the agro-tech fields.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Sarona Ventures is a global venture capital firm backing exceptional founders in enterprise software, AI, and transformative technologies from pre-seed to Series B.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 55
- Round size: Seed $150k–$9M; Pre-Seed $100k–$1M; Series A $150k–$25M
- Lead/follow: 7% lead, 93% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- WINN.AI — WINN.AI helps sales team run better sales calls and win more deals with real-time guidance that's tuned to every rep, every deal, and every call.
- Visitt.io — Come to Visitt and see why CRE & multifamily property management, tenant experience and building operation teams all love our easy to use tools & tenant apps
- Crowded — Banking for Greek Life that allows you to seamlessly pay dues, P2P transfers, deposits, and make payments with your virtual debit card. Tailored tools for events, ticketing, chat organizational management and more.
fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, Norway
Investor stats
- Total investments: 44
- Round size: Seed $1.6M–$10M; Pre-Seed $300k–$6M; Series A $11M–$21M
- Lead/follow: 11% lead, 89% follow
- Last fund: Likely actively investing — fresh fund, raised $7.9M in 2025
Portfolio highlights
- Kimba — Kimba is an adaptive scent sleep system that uses sleep and biometric data to deliver personalized, natural-origin scents at specific moments throughout the night, designed to actively improve sleep rather than simply track it.
- CopilotKit — The Enterprise-Ready Frontend Stack for Agents. CopilotKit lets you integrate LLMs or agents with real-time context, UI control, and full flexibility.
- Shifters AI — Shifters builds autonomous robotic teams for dangerous ground missions.
ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series C, Venture - Series Unknown
- Geography: Israel, United States
Investor stats
- Total investments: 15
- Round size: Series A $4.4M–$17M; Series C $30M–$55M; Venture - Series Unknown $11M–$105M
- Lead/follow: 67% lead, 33% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Navina — Navina uses medically-informed AI to replace disorganized patient data with an intuitive Patient Portrait - a logical grid that makes it possible for every primary care physician to assess even the most complex cases in minutes. Designed for and loved by physicians, Navina allows for high quality and empathic patient care, resulting in better treatment, reduced missed diagnoses and enhanced financial performance for providers and payers.
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
- Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
J- Ventures is a Silicon Valley based group of VC funds with over $60m under management. Backed by 400+ leading Investors ( 140+ Serial founders, 100+ VCs, 170+ Fortune 500 Executives) as LPs. Our active-LP venture fund brings the power of this connected & intellectual capital to add real value to the companies we invest in and create aremarkable difference by helping our founders grow and scale to markets quicker. Based in Silicon Valley with investors from 15 communities - Tel Aviv, NYC, LA, London, Miami, Boston, and more. Since 2016 the group made over 50 investments, 4 unicorns and over 10 exits.
Show more...Investment focus
- Industry: Software, Health Care, Machine Learning
- Stage:Series A, Seed, Pre-Seed
- Geography: United States, Israel
Investor stats
- Total investments: 83
- Round size: Seed $3M–$7.2M; Pre-Seed $200k–$4M; Series A $8M–$27M
- Lead/follow: 2% lead, 98% follow
- Last fund: Likely actively investing — fresh fund, raised $36M in 2025
Portfolio highlights
- Zenskar — Zenskar seamlessly manages complex subscription and usage based billing. Meter high throughput data, and automate revenue accounting, analytics & dunning.
- CopilotKit — The Enterprise-Ready Frontend Stack for Agents. CopilotKit lets you integrate LLMs or agents with real-time context, UI control, and full flexibility.
- RAAAM Memory Technologies Ltd. — RAAAM provides a unique on-chip memory technology that offers the highest-density embedded memory solution in any standard CMOS process.RAAAM develops a high-density memory technology that allows for up to 50% higher on-chip memory density with no cost, complexity, or performance-penalty.
Grove Ventures is a leading early-stage venture capital fund in Israel. It partners with seed and early-stage founders
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 76
- Round size: Seed $3.3M–$20M; Series A $8M–$50M; Series B $22M–$74M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $1.5M in 2024
Portfolio highlights
- Particula — Particula brings new life into Rubik's cube, dice, and chess using AI, connectivity, and interactivity. Enter a smart games world with modern versions of classics!
- LimitlessCNC — Limitless CNC is an AI-powered technology intended to improve CNC machining operations. It offers an AI CAM agent that works with NX-CAM to give industry-specific strategies and operations.
- FormX — California's trusted sustainable builders. FormX delivers fully customized single-family homes, ADUs, and backyard offices built faster with component-based modular construction.
PipelBiz enables companies to raise capital from an unlimited number of investors without the need of a prospectus
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Equity Crowdfunding, Seed
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 50
- Round size: Seed $150k–$2.8M; Equity Crowdfunding $152k–$1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable
- Pickspace — Run rent collection, accounting, leasing, maintenance and owner reporting on one AI-native platform. Book a demo today.
- Nina Medical Ltd. — World's first truly non-invasive treatment for enlarged prostate (BPH). Safe, precise, and liberating care for millions of men. Treat early with dignity.
Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Life Science
- Stage:Seed, Series B, Series F
- Geography: Israel
Investor stats
- Total investments: 8
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
- Splisense — Transformative RNA Based Treatments -Antisense Oligonucleotides- Targeting the Root Cause of Pulmonary Diseases Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable pulmonary diseases.
- Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
Healthcare innovation wherever it originates.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 80
- Round size: Series A $5.9M–$63M; Series B $18M–$55M; Series C $300k–$100M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
- Manus Neurodynamica — Manus Neurodynamica is a triage device to support early diagnostics in Parkinson's disease.
- Glyphic Biotechnologies — We sequence proteins. Glyphic Biotechnologies is decoding the human proteome through full coverage, de novo protein sequencing at single molecule resolution to enable the development of novel therapeutics and diagnostics and, ultimately, a deeper understanding of life itself.
Explore Arkin Capital: A leading multi-asset manager driving strategic investments across health, technology, equity, real estate and more
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: Israel, United States, Switzerland
Investor stats
- Total investments: 32
- Round size: Seed $2M–$6M; Series A $15M–$29M; Series B $23M–$95M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely actively investing — fresh fund, raised $100M in 2026
Portfolio highlights
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.
- Werewolf Therapeutics — Developing transformative conditionally activated proinflammatory immune modulating medicines to unleash a powerful attack on cancer.
TAU Ventures is an early-stage focused venture capital fund affiliated with Tel Aviv University, investing in the next generation of impactful home-grown technology companies. At the heart of the start-up nation, TAU Ventures invests the first capital into startups and is dedicated to helping them transform their ideas into global businesses.TAU Ventures cultivates an innovation ecosystem by combining the resources and global network of Tel Aviv University, strong industry connections, and a supportive home-base for founders. Together with its world-leading team of experienced mentors, TAU Ventures empowers startups in their critical, early steps. At its 1000 sq meter co-working office space located in Tel Aviv, the team works shoulder to shoulder with their portfolio companies, nurturing their growth by drawing on the strength of its innovation ecosystem on a daily basis.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Enterprise Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 46
- Round size: Seed $1M–$5.3M; Pre-Seed $370k–$3M; Series A $6M–$28M
- Lead/follow: 9% lead, 91% follow
- Last fund: Likely still investing — raised $50M in 2021
Portfolio highlights
- Deeto — Deeto is a growth-enablement platform that leverages satisfied customers' experiences to help businesses close more deals, faster.
- Zenyard — Zenyard develops an AI agent platform focused on software reverse engineering. The platform automates repetitive manual tasks in analyzing binaries and decompiled code so security and research teams can focus on understanding behavior and intent. Zenyard supports reverse engineers by providing full-file context and workflow assistance. It targetsuse cases such as malware analysis, vulnerability research, and code auditing. The company serves technical teams that need to accelerate and standardize complex reverse engineering processes.
- XTEND — Explore cutting-edge military-grade tactical drones powered by AI, designed to enhance strategic capabilities and mission success in complex environments.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 297
- Round size: Seed $150k–$5.3M; Series A $2.1M–$25M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $50M in 2023
Portfolio highlights
- CyVek — CyVek, Inc. engages in the development of a platform technology for measuring analytes in biological samples. The company was incorporated in 2008 and is based in Wallingford, Connecticut.
- eBrevia — Analyze contracts at scale, extract key data, and identify risk with eBrevia. Draft and redline agreements in Microsoft Word with DraftPro.
- Axerion Therapeutics — Axerion Therapeutics, Inc. is a private Connecticut-based biotechnology company focused on developing innovative therapeutics for neurological diseases and injuries with significant unmet medical need, including Alzheimer’s disease and spinal cord injury.Axerion was established in New Haven to develop and commercialize intellectual propertylicensed from Dr. Stephen Strittmatter’s laboratory at Yale University. Axerion’s proprietary technology platforms include blockers of ß-amyloid (Aß) oligomers binding to Prion Proteins (PrP) on the cell surface of neurons as a novel therapeutic target for Alzheimer’s disease and Nogo Receptor decoy protein for recovery of neurological function in spinal cord injury and other neurological diseases.
XTX Ventures is the venture capital arm of XTX Markets. XTX Markets is a leading, innovation-driven algorithmic trading firm.XTX Ventures focuses on early stage startups (Seed to Series A) applying machine learning and leverages XTX Markets’ deep expertise in ML and financial technology to help grow and enhance those businesses. We are geographyand industry agnostic.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Series A, Seed
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 97
- Round size: Seed $2M–$7.6M; Series A $6M–$60M
- Lead/follow: 21% lead, 79% follow
- Last fund: Likely still investing — raised $9.6M in 2024
Portfolio highlights
- Jenesys AI — Meet Jack, your AI-powered bookkeeping agent, automates line-item extraction, GL coding, and bank reconciliation with real-time insights.
- Qureight — Pioneering data curation to solve complex diseases
- Maven Robotics — Maven Robotics is building the world's leading general purpose AI robots.
Pfizer provides access to safe and effective and affordable medicines and health care services. They have a portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and they have an industry-leading pipeline of promising new products that havethe potential to challenge some of the most feared diseases of their time, like Alzheimer's disease and cancer.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Post-IPO Equity, Seed
- Geography: United States, Israel, France
Investor stats
- Total investments: 58
- Round size: Seed $800k–$11M; Series A $4M–$310M; Post-IPO Equity $25M–$320M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- CellCentric — CellCentric’s primary programme targets a deubiquitinase (DUB) enzyme which is strongly associated with prostate cancer, a leading cause of mortality among men. The target modulates the androgen receptor pathway and can potentially combat the multiple resistance mechanisms seen with recently approved prostate cancer drugs such Xtandi and Zytiga.The programme also has potential clinical utility in non-small cell lung, breast and colon cancer.
- Promise Bio — Promise Bio develops a virtual AI platform that helps to identify multiple Post-Translational Modifications in proteins from a single blood sample. It helps to cure chronic diseases.
- RNT Health Insights — RNT Health Insights is developing an AI assisted detection tool, that aids endoscopists in the real-time detection of debilitating upper gastrointestinal lesions, including early gastric cancer and associated malignant lesions, having received the US FDA Breakthrough Device Designation for their product.
A dedicated to China-Israel cross border investment.
Show more...Investment focus
- Industry: Health Care, Medical Device, Eyewear
- Stage:Series A, Seed, Series B
- Geography: Israel, France, United States
Investor stats
- Total investments: 10
- Round size: Seed $3.6M–$3.6M; Series A $6.6M–$11M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- EyeYon — EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer TechnologyIncubator.
- TECLens — TECLens is creating a crosslinking technology that may accurately fix vision issues in healthy eyes as well as treat keratoconus. It provides patients with presbyopia with the ability to regain their ability to read at a distance, controls children's progressive myopia, corrects adult vision problems like hyperopia and low-order myopia, andmore.
- Laclarée — Laclarée develops a pair of adaptive eyeglasses for presbyopia. Its patented technology allows the eyeglasses to adapt in real-time to the scene viewed by the wearer. This major innovation will help milllions of people 45+ years, who are not satisfied with current solutions (progressive lenses, multiple pairs, etc...).
Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Israel, United States
Investor stats
- Total investments: 39
- Round size: Seed $55k–$7M; Series A $7.5M–$50M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
- Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
- Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
iAngels is a VC and angel investment platform that leverages due diligence and analytics to enable accredited investors around the world the ability to invest in early-stage technology deals in Israel.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 138
- Round size: Seed $900k–$10M; Pre-Seed $120k–$400k; Series A $4.2M–$22M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $56M in 2021
Portfolio highlights
- Nas Daily —
- Recapp — Recapp is a sports-video platform that creates a single, scrollable feed by compiling and arranging game highlights from various leagues.
- Lasso Security — Lasso Security defends the LLM frontier with advanced LLM Cybersecurity solutions. Embrace progress and strengthen your AI cybersecurity posture
New York Angels is one of the oldest, most prominent angel investment groups in the country. New York Angels has offered early-stage entrepreneurs funding, mentoring, connections and more for over 20 years. Angel investors join New York Angels for their extensive, experienced network, increased de
Show more...Investment focus
- Industry: Software, Health Care, Mobile
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 378
- Round size: Seed $325k–$5M; Series A $1.1M–$10M; Series B $2M–$15M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $2.4M in 2022
Portfolio highlights
- Solidec — Solidec is the pathway to emission-free compounds, beginning with hydrogen peroxide.
- Skyfire AI — Drone automation and AI, from America's most trusted public safety UAS experts.
- Dirty Shirley — Dirty Shirley is a beverage company that produces and supplies canned cocktails.
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI).
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 18
- Round size: Series A $4M–$55M; Series B $15M–$40M
- Lead/follow: 11% lead, 89% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- TytoCare — TytoCare offers the Home Smart Clinic - for accessible, high-quality primary care from home, with no compromises.
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
TAL Ventures (TAL) is an Israel based Venture Capital group with deep ties to the Israel high-tech ecosystem.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: Israel, United States, Cyprus
Investor stats
- Total investments: 59
- Round size: Seed $3M–$12M; Pre-Seed $2.1M–$4M; Series A $5M–$25M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — raised $4.7M in 2022
Portfolio highlights
- TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
- Yuki — Reduce warehouse waste, prevent budget spikes, and keep queries fast across Snowflake and BigQuery. Yuki keeps AI workloads under control with budgets and priorities built in, optimizing in real time with zero engineer effort.
- Majestic Labs ai — Majestic Labs ai builds power-efficient AI servers for the largest and most advanced AI workloads.
Established in 1997 as the venture arm of XT Holdings, XT Hi-Tech is one of the early investors in Israeli startups. Since inception, we have invested in over 80 companies in various technology categories and at different stages, including Phytech, Checkmarx, Enzymotec, Cymbio, Sofwave, and Lumenis.
Show more...Investment focus
- Industry: Software, Health Care, Travel
- Stage:Series A, Seed, Series B
- Geography: Israel, Singapore, United States
Investor stats
- Total investments: 23
- Round size: Seed $3.2M–$7.4M; Series A $6M–$32M; Series B $11M–$100M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Duve — Give your guests the guest experience they deserve with Duve's guest experience platform for hotels, vacation rentals, hostels and more
- Localbird — Explore unique experiences, on-demand services, rentals, you name it.
- ORION Security — ORION detects and prevents data loss across SaaS, email, cloud, AI tools, and endpoints using intelligent, context-aware, proprietary AI agents.
Health Care VC funding in Israel at a glance
Stats across 1.7k deals from 1.3k investors.
Access all 1323 VC funds in Israel Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds in Israel investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 1323 VC funds investing in Israel Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!